| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +21.5K | +21.84% | $0.00 | 120K | Mar 31, 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | -$223K | -11.9K | -9.91% | $18.80 | 108K | Mar 31, 2024 | Direct | |
| transaction | OGN | Common Stock | Options Exercise | $0 | +39K | +36.11% | $0.00 | 147K | Mar 31, 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | -$405K | -21.6K | -14.67% | $18.80 | 125K | Mar 31, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -21.5K | -50% | $0.00 | 21.5K | Mar 31, 2024 | Common Stock | 21.5K | Direct | F1, F2 | |
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -39K | -33.33% | $0.00 | 77.9K | Mar 31, 2024 | Common Stock | 39K | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
| F2 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. |
| F3 | On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. |